We show that the ATO+VEN combination induces augmented ROS signaling through down-regulation of the Akt-Nrf2 antioxidant pathway by VEN, which was associated with decreased FAO and OXPHOS and increased apoptosis and DNA fragmentation in LSC-enriched AML progenitor cells. Here, NFE2L2 is linked to acute myeloid leukemia.